Syndax Pharmaceuticals, Inc. ($SNDX)
Filing Information
| Accession Number | 0001193125-26-043813 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 10, 2026 |
| Document Date | Feb 9, 2026 |
| Document | View SEC Filing |
Transactions
1
Total Shares
3,410
Total Value
$71,705.48
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Common Stock | โ | Feb 9, 2026 | Sale | 3,410 | $21.03 | $71,705.48 | 140,429 | Direct | โ | View Details |